Synthesis of α-hydroxytamoxifen and its 4-hydroxy analog

Organic Preparations and Procedures International

Volumn 35, Issue 2, 2003, Pages 231-238

  Lashley, M R ^a   Dicus, C W ^a   Nantz, M H ^a   Brown, K ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA HYDROXY 4 HYDROXYTAMOXIFEN; ALPHA HYDROXYTAMOXIFEN; TAMOXIFEN; UNCLASSIFIED DRUG;

ADDITION REACTION; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG SYNTHESIS; HYDROXYLATION; INFRARED SPECTROSCOPY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 0037391395     PISSN: 00304948     EISSN: 19455453     Source Type: Journal    
DOI: 10.1080/00304940309355839     Document Type: Article

References (31)

1. T. J. Powles, Semin. Oncol., 24, 1 (1997).
2. D. A. Tonetti, V. C. Jordan, Molec. Med. Today, 218 (1996).
3. P. H. Brown and S. M. Lippman, Breast Cancer Res. Treat., 62, 1 (2000).
4. B. Fisher, J. P. Costantino, C. K. Redmond, E. R. Fisher, D. L. Wickerham and W. M. Cronin, J. Natl. Cancer Inst., 86, 527 (1994).
5. R. E. Curtis, J. D. Boice Jr., D. A. Shriner, B. F. Hankey and J. F. Fraumeni Jr., J. Natl. Cancer Inst., 88, 832 (1996).
6. R. E. Cuenca, J. Giachino, M. A. Arrendondo, R. Hempling and S. B. Edge, Cancer, 77, 2058 (1996).
7. K. Brown, R. T. Heydon, R. Jukes, I. N. H. White and E. A. Martin, Carcinogenesis, 20, 2011 (1999).
8. P. Greaves, R. Goonetilleke, G. Nunn, J. Topham and T. Orton, Cancer Res., 53, 3919(1993).
9. D. H. Phillips, Carcinogenesis, 22, 839 (2001).
10. M. Kitagawa, A. Ravindemath, N. Suzuki, R. Rieger, I. Terashima, A. Umemoto and S. Shibutani, Chem. Res. Toxicol., 13, 761 (2000).
11. E. A. Martin, R. T. Heydon, K. Brown, J. E. Brown, C. K. Lim, I. N. H. White and L. L. Smith, Carcinogenesis, 19, 1061 (1998).
12. M. R. Osbome, A. Hewer, I. R. Hardcastle, P. L. Carmichael and D. H. Phillips, Cancer Res., 56, 66 (1996).
13. H. Phillips, P. L. Carmichael, A. Hewer, K. J. Cole, G. K. Poon, Cancer Res., 54, 5518 (1994).
14. S. Shibutani, A. Ravindemath, N. Suzuki, I. Terashima, S. M. Sugarman, A. P. Grollman and M. L. Pearl, Carcinogenesis, 21, 1461 (2000).
15. S. Shibutani, N. Suzuki, I. Terashima, S. M. Sugarman, A. P. Grollman and M. L. Pearl, Chem. Res. Toxicol. 12, 646 (1999).
16. W. Davis, S. Venitt and D. H. Phillips, Carcinogenesis, 19, 861 (1998).
17. S. Shibutani and L. Dasaradhi, Biochemistry, 36, 13010 (1997).
18. I. R. Hardcastle, M. N. Horton, M. R. Osborne, A. Hewer, M. Jarman and D. H. Phillips, Chem. Res. Toxicol., 11, 369 (1998).
19. M. R. Osborne, W. Davis, A. J. Hewer, I. R. Hardcastle and D. H. Phillips, Chem. Res. Toxicol., 12, 151 (1999).
20. F. A. Beland, L. P. McDaniel and M. M. Marques, Carcinogenesis, 20, 471 (1999).
21. A. B. Foster, M. Jarman, O.-T. Leung, R. McCague, G. Leclercq and N. Devleeshouwer, J. Med. Chem., 28, 1491 (1985).
22. C. F. Longfellow and A. O. Jackson, ChemAbstr., 42, 1029 (1948); USPN 2, 429, 556.
23. C. K. Osbome, E. Coronado, D. C. Allred, V. Weibe and M. J. DeGregorio, J. Nat. Cancer Inst., 83, 1477(1991).
24. S. Shibutani, L. Dasaradhi, I. Terashima, E. Banoglu and M. W. Duffel, Cancer Res., 58, 647(1998).
25. G. R. Bedford, A. L. Walpole and B. Wright, J. Med. Chem., 17, 1 (1974).
26. M. R. Lashley, E. J. Niedzinski, J. M. Rogers, M. S. Denison and M. H. Nantz, Bioorganic & Med. Chem., 10, 4075 (2002).
27. Z. Xiao and J. W. Timberlake, Tetrahedron, 54, 4211 (1998).
28. P. R. Carlier, K. M. Lo, M. M.-C. Lo, P. C.-K. Lo and C. W.-S. Lo, J. Org. Chem., 62, 6316 (1997).
29. J. J. P. Zhou, B. Zhong and R. B. Silverman, J. Org. Chem., 60, 2261 (1995).
30. P. R. Carlier and K. M. Lo, J. Org. Chem., 59, 4053 (1994).
31. J.-L. Luche, J. Am. Chem. Soc., 100, 2226 (1978).